SGLT2, A New Class of Diabetes Drugs
A new class of diabetes drug was approved in 2013. The class is SGLT2 and the brand name is Invokana with as generic name of canagliflozin....
https://about-diabetic.blogspot.com/2013/11/sglt2-new-class-of-diabetes-drugs.html
A new class of diabetes drug was
approved in 2013. The class is SGLT2 and the brand name is Invokana
with as generic name of canagliflozin. Canagliflozin is to improve
glycemic control in adults with type 2 diabetes in cooperation with
diet and exercise. The drug has been studied as monotherapy and in
combination with other common treatments for type 2 diabetes
including metformin,
